Zenlabs EthicaBOM:530697 -4.96%53 Operating Margin % is 1.38% as of Mar. 2026, which is 33% below its 10-year median of 2.05. GuruFocus rates BOM:530697 with a GF Score™ of 53/100 and a GF Value™ of ₹29.37 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, Zenlabs Ethica ranks worse than 63.25% on this metric.
Zenlabs Ethica Ltd operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Zenlabs Ethica's Operating Margin % or its related term are showing as below:
BOM:530697'
s Operating Margin % Range Over the Past 10 Years
Min: -1.63 Med: 2.05 Max: 2.77
Current: 1.9
BOM:530697's Operating Margin % is ranked worse than 63.25% of 117
companies
in the Medical Distribution industry
Industry Median: 3.05
vs BOM:530697: 1.90
Zenlabs Ethica's 5-Year Average Operating Margin % Growth Rate was 1.10% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Zenlabs Ethica Operating Margin % Related Terms
Zenlabs Ethica Operating Margin % Historical Data
* Premium members only.
The historical data trend for Zenlabs Ethica's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530697 vs MCK, CAH, COR: Operating Margin % Comparison
For the Medical Distribution subindustry, Zenlabs Ethica's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenlabs Ethica Operating Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zenlabs Ethica's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Zenlabs Ethica's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Zenlabs Ethica's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenlabs Ethica (BOM:530697) has a Operating Margin % of 1.38% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Zenlabs Ethica and its competitors. This is 33% below median its historical median of 2.05. According to the industry distribution chart, Zenlabs Ethica ranks #74 out of 117 companies in the Medical Distribution industry, placing it in the top 63.2%.
Is Zenlabs Ethica's Operating Margin % too high?
Zenlabs Ethica's current Operating Margin % of 1.38% is 33% below median its 10-year median of 2.05. The Medical Distribution industry median Operating Margin % is 3.05. Zenlabs Ethica's value of 1.38% is 54.8% below this industry median. Based on the distribution chart, Zenlabs Ethica ranks #74 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Zenlabs Ethica has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zenlabs Ethica's Operating Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Zenlabs Ethica ranks #74 out of 117 companies for Operating Margin %. This places Zenlabs Ethica in the lower half of its industry. The industry median Operating Margin % is 3.05. Zenlabs Ethica's value of 1.38% is 54.8% below this benchmark. While the company's 10-year median is 2.05 vs. the industry median of 3.05, Zenlabs Ethica has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Distribution company?
The median Operating Margin % among Medical Distribution companies is 3.05, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zenlabs Ethica's current Operating Margin % of 1.38% is 54.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Zenlabs Ethica and its competitors. For the Medical Distribution industry, the median Operating Margin % is 3.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenlabs Ethica's current Operating Margin % is 1.38%, which is 33% below median its own 10-year median of 2.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenlabs Ethica stock overvalued right now?
Based on GuruFocus' analysis, Zenlabs Ethica (BOM:530697) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹29.37, compared to a current price of ₹32.60 — trading 11% above its estimated fair value. The current Operating Margin % is 1.38%, which is 33% below median its 10-year median of 2.05 and 54.8% below the Medical Distribution industry median of 3.05. Zenlabs Ethica's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Zenlabs Ethica (BOM:530697), the current Operating Margin % is 1.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenlabs Ethica (BOM:530697) Overvalued in 2026?
Based on GuruFocus' analysis, Zenlabs Ethica stock appears to be overvalued.
The current stock price of ₹32.60 is trading 11% above its estimated GF Value™ of ₹29.37.
GuruFocus considers Zenlabs Ethica to be Modestly Overvalued.
Key valuation signals for BOM:530697:
Operating Margin %: 1.38% (33% below median its 10-year median of 2.05)
GF Value™: ₹29.37 vs. price of ₹32.60 (11% above fair value)
Industry Position: 54.8% below the Medical Distribution median (#74 of 117)
No single metric tells the full story. See the BOM:530697 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
53GF Score
Get the complete analysis for BOM:530697
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530697 has been successfully added to your 
